Please fill out your email address if you want to be notified when the product is back in-stock.
To delight our customers and patients with the highest quality products and services for the treatment of Obstructive Sleep Apnea (OSA).
SomnoMed is a publicly traded company on the Australian Stock Exchange (ASX:SOM). Please visit our Investor section.
© 2020 SomnoMed.com.
Dear SomnoMed Customers, Partners, and Friends,
We currently face unprecedented times around the world due to the COVID-19 virus. This has far-reaching implications for life in general as well as normal business practices.
SomnoMed’s priority at this time is to keep our staff and employees around the world as safe as we can. To this end, we have implemented a policy of workplace flexibility, allowing our teams to work from home to manage both their work and family commitments. We’ve stopped traveling as per government guidelines, but we are on-line, and just a phone call or email away, if you need us to support you or your patients.
Finally, I would like to reassure you that we are doing everything possible to keep our global supply chain open and to ensure that SomnoMed stays financially strong so that we remain available to you and for your patients when you need us.
Our thoughts are with you as we fight this virus together.
Kind regards
Neil Verdal-Austin
CEO, Somnomed
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
